Interplay between innate and adaptive immunity in the development of non-infectious uveitis

Progress in Retinal and Eye Research

Volumn 31, Issue 2, 2012, Pages 182-194

  Willermain, François ^a,b   Rosenbaum, James T ^c   Bodaghi, Bahram ^d   Rosenzweig, Holly L ^c   Childers, Sarah ^c   Behrend, Travis ^c   Wildner, Gerhild ^e   Dick, Andrew D ^f,g  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Adaptive immunity; Autoimmunity; Autoinflammation; Innate immunity; Uveitis

Indexed keywords

AZATHIOPRINE; CANAKINUMAB; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CRYOPYRIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA CONVERTING ENZYME; METHOTREXATE; MEVALONATE KINASE; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RETINOIC ACID INDUCIBLE PROTEIN I; RILONACEPT; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTOINFLAMMATORY DISEASE; BEHCET DISEASE; BLAU SYNDROME; CINCA SYNDROME; CROHN DISEASE; DRUG HALF LIFE; FAMILIAL MEDITERRANEAN FEVER; HUMAN; IMMUNOREACTIVITY; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INJECTION SITE REACTION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MEVALONATE KINASE DEFICIENCY; MOLECULAR MIMICRY; PAPA SYNDROME; PFAPA SYNDROME; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; UPPER RESPIRATORY TRACT INFECTION; UVEITIS;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; MICE; RABBITS; RATS; T-LYMPHOCYTES; UVEITIS;

EID: 84857117640     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2011.11.004     Document Type: Review

References (128)

1. Abu El-Asrar A.M., Abouammoh M., Al-Mezaine H.S. Tuberculous uveitis. Int. Ophthalmol. Clin. 2010, 50:19-39.
2. Allensworth, J.J., Planck, S.R., Rosenbaum, J.T., Rosenzweig, H.L. Investigation of the differential potentials of TLR agonists to elicit uveitis in mice. J. Leukoc. Biol. Sep 20, in press. [Epub ahead of print].
3. Arostegui J.I., Arnal C., Merino R., Modesto C., Antonia Carballo M., Moreno P., García-Consuegra J., Naranjo A., Ramos E., de Paz P., Rius J., Plaza S., Yagüe J. NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum. 2007, 56:3805-3813.
4. Banerjee D., Dick A.D. Blocking CD200-CD200 receptor axis augments NOS-2 expression and aggravates experimental autoimmune uveoretinitis in Lewis rats. Ocul. Immunol. Inflamm. 2004, 12:115-125.
5. Billingham R.E., Brent L., Medawar P.B. Actively acquired tolerance of foreign cells. Nature 1953, 172:603-606.
6. Broderick C.A., Smith A.J., Balaggan K.S., Georgiadis A., Buch P.K., Trittibach P.C., Barker S.E., Sarra G.M., Thrasher A.J., Dick A.D., Ali R.R. Local administration of an adeno-associated viral vector expressing IL-10 reduces monocyte infiltration and subsequent photoreceptor damage during experimental autoimmune uveitis. Mol. Ther. 2005, 12:369-373. Erratum in: 2006. 13, 829.
7. Calder C.J., Nicholson L.B., Dick A.D. A selective role for the TNF p55 receptor in autocrine signaling following IFN-gamma stimulation in experimental autoimmune uveoretinitis. J. Immunol. 2005, 175:6286-6293.
8. Carter D.A., Dick A.D. CD200 maintains microglial potential to migrate in adult human retinal explant model. Curr. Eye Res. 2004, 28:427-436.
9. Casadevall A., Pirofski L.A. Host-pathogen interactions: basic concepts of microbial commensalism, colonization, infection and disease. Infect. Immun. 2000, 68:6511-6518.
10. Caspi R.R. A look at autoimmunity and inflammation in the eye. J. Clin. Invest. 2010, 120:3073-3083.
11. Caspi R.R. Understanding autoimmune uveitis through animal models. The Friedenwald Lecture. Invest. Ophthalmol. Vis. Sci. 2011, 52:1872-1879.
12. Chang J.H., McCluskey P.J., Wakefield D. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br. J. Ophthalmol. 2006, 90:103-108.
13. Chen, M., Copland, D.A., Zhao, J., Liu, J., Forrester, J.V., Dick, A.D., Xu, H. Persistent Inflammation subverts thrombospondn-1 induced regulation of retinal angiogenesis and is driven by CCR2 ligation. Am. J. Pathol. Nov 7, in press. [Epub ahead of print].
14. Chi Z.L., Hayasaka Y., Zhang X.Y., Cui H.S., Hayasaka S. S100A9-positive granulocytes and monocytes in lipopolysaccharide-induced anterior ocular inflammation. Exp. Eye Res. 2007, 84:254-265.
15. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994, 271:698-702.
16. Cooper M.D., Alder M.N. The evolution of adaptive immune systems. Cell 2006, 124:815-822.
17. Copland D.A., Calder C.J., Raveney B.J., Nicholson L.B., Phillips J., Cherwinski H., Jenmalm M., Sedgwick J.D., Dick A.D. Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis. Am. J. Pathol. 2007, 171:580-588.
18. Copland D.A., Hussain K., Baalasubramanian S., Hughes T.R., Morgan B.P., Xu H., Dick A.D., Nicholson L.B. Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. Clin. Exp. Immunol. 2010, 159:303-314.
19. Cutrufello N.J., Karakousis P.C., Fishler J., Albini T.A. Intraocular tuberculosis. Ocul. Immunol. Inflamm. 2010, 18:281-291.
20. Deeg C.A., Raith A.J., Amann B., Crabb J.W., Thurau S.R., Hauck S.M., Ueffing M., Wildner G., Stangassinger M. CRALBP is a highly prevalent autoantigen for human autoimmune uveitis. Clin. Dev. Immunol. 2007, 2007:39245.
21. DeVoss J., Hou Y., Johannes K., Lu W., Liou G.I., Rinn J., Chang H., Caspi R.R., Fong L., Anderson M.S. Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J. Exp. Med. 2006, 203:2727-2735.
22. Dick A.D., McMenamin P.G., Körner H., Scallon B.J., Ghrayeb J., Forrester J.V., Sedgwick J.D. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. Eur. J. Immunol. 1996, 26:1018-1025.
23. Dick A.D., Duncan L., Hale G., Waldmann H., Isaacs J. Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis. J. Autoimmun. 1998, 11:255-264.
24. Dick A.D., Broderick C., Forrester J.V., Wright G.J. Distribution of OX2 antigen and OX2 receptor within retina. Invest. Ophthalmol. Vis. Sci. 2001, 42:170-176.
25. Dick A.D., Okada A.A., Forrrester J.V. Practical Manual of Intraocular Inflammation 2008, Informa.
26. Dollfus H., Hafner R., Hofmann H.M., Russo R.A., Denda L., Gonzales L.D., DeCunto C., Premoli J., Melo-Gomez J., Jorge J.P., Vesely R., Stubna M., Dufier J.L., Prieur A.M. Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood. Arch. Ophthalmol. 2000, 118:1386-1392.
27. Doycheva D., Pfannenberg C., Hetzel J., Deuter C.M., Pavesio C., Kempf V.A., Schuelen E., Aschoff P., Rao N., Zierhut M. Presumed tuberculosis-induced retinal vasculitis, diagnosed with positron emission tomography (18F-FDG-PET/CT), aspiration biopsy, and culture. Ocul. Immunol. Inflamm. 2010, 18:194-199.
28. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project. JAMA 1999, 282:677-686.
29. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants?. J. Leukoc. Biol. 2010, 87:989-999.
30. Fang J., Fang D., Silver P.B., Wen F., Li B., Ren X., Lin Q., Caspi R.R., Su S.B. The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model. Invest. Ophthalmol. Vis. Sci. 2010, 51:3092-3099.
31. Fine P.E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995, 346:1339-1345.
32. Flynn J., Chan J. Tuberculosis: latency and reactivation. Infect. Immun. 2001, 69:4195-4201.
33. Forrester J.V., Worgul B.V., Merriam G.R. Endotoxin-induced uveitis in the rat. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. 1980, 213:221-233.
34. Forrester J.V., Xu H., Lambe T., Cornall R. Immune privilege or privileged immunity?. Mucosal Immunol. 2008, 1:372-381.
35. Forrester J.V., Xu H., Kuffová L., Dick A.D., McMenamin P.G. Dendritic cell physiology and function in the eye. Immunol. Rev. 2010, 234:282-304.
36. Friswell M., Campbell B., Rhodes J. The role of bacteria in the pathogenesis of inflammatory bowel disease. Gut Liver 2010, 4:295-306.
37. Fritz J.H., Le Bourhis L.L., Sellge G., Magalhaes J.G., Fsihi H., Kufer T.A., Collins C., Viala J., Ferrero R.L., Girardin S.E., Philpott D.J. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 2007, 26:445-459.
38. Garip A., Diedrichs-Möhring M., Thurau S.R., Deeg C.A., Wildner G. Uveitis in a patient treated with Bacille-Calmette-Guérin: possible antigenic mimicry of mycobacterial and retinal antigens. Ophthalmology 2009, 116:2457-2462.
39. Geijtenbeek T.B.H., Gringhuis S.J. Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 2009, 9:465-479.
40. Glocker E.O., Hennigs A., Nabavi M., Schäffer A.A., Woellner C., Salzer U., Pfeifer D., Veelken H., Warnatz K., Tahami F., Jamal S., Manguiat A., Rezaei N., Amirzargar A.A., Plebani A., Hannesschläger N., Gross O., Ruland J., Grimbacher B. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med. 2009, 361:1727-1735.
41. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
42. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5:953-964.
43. Goriely S., Neurath M.F., Goldman M. How microorganisms tip the balance between interleukin-12 family members. Nat. Rev. Immunol. 2008, 8:81-86.
44. Gül A. Behçet's disease as an autoinflammatory disorder. Curr. Drug Targets Inflamm. Allergy 2005, 4:81-83.
45. Guo P., Hirano M.A., Herrin B.R., Li J., Yu C., Sadlonova A., Cooper M.D. Dual nature of the adaptive immune system in lampreys. Nature 2009, 459:796-801.
46. Gupta V., Gupta A., Rao N.R. Intraocular tuberculosis-an update. Surv. Ophthalmol. 2007, 52:561-587.
47. Gupta A., Bansal R., Gupta V., Sharma A., Bambery P. Ocular signs predictive of tubercular uveitis. Am. J. Ophthalmol. 2010, 149:562-570.
48. Hedrick S.M. Immune system: not so superior. Science 2009, 325:1623-1624.
49. Hegde V., Dean F. Bilateral panuveitis and optic neuritis following Bacillus Calmette-Guerin (BCG) vaccination. Acta Paediatr. 2005, 94:635-636.
50. Hirose S., Tanaka T., Nussenblatt R.B., Palestine A.G., Wiggert B., Redmond T.M., Chader G.J., Gery I. Lymphocyte responses to retinal-specific antigens in uveitis patients and healthy subjects. Curr. Eye Res. 1988, 7:393-402.
51. Huerta C., Rivero E., Rodriguez L.A. Incidence and risk factors for psoriasis in the general population. Arch. Dermatol. 2007, 143:1559-1565.
52. Jabs D.A., Houk J.L., Bias W.B., Arnett F.C. Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am. J. Med. 1985, 78:801-804.
53. Jabs D.A., Nussenblatt R.B., Rosenbaum J.T., Standardization of Uveitis Nomenclature (SUN) Working Group Standardization of uveitis nomenclature for reporting clinical data. Am. J. Ophthalmol. 2005, 140:509-516. Results of the First International Workshop.
54. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 1989, 54:1-13.
55. Jiang G., Ke Y., Sun D., Wang Y., Kaplan H.J., Shao H. Regulatory role of TLR ligands on the activation of autoreactive T cells by retinal astrocytes. Invest. Ophthalmol. Vis. Sci. 2009, 50:4769-4776.
56. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat. Immunol. 2010, 11:373-383.
57. Kerr E.C., Copland D.A., Dick A.D., Nicholson L.B. The dynamics of leukocyte infiltration in experimental autoimmune uveoretinitis. Prog. Retin. Eye Res. 2008, 27:527-535.
58. Kezic J., Xu H., Chinnery H.R., Murphy C.C., McMenamin P.G. Retinal microglia and uveal tract dendritic cells and macrophages are not CX3CR1 dependent in their recruitment and distribution in the young mouse eye. Invest. Ophthalmol. Vis. Sci. 2008, 49:1599-1608.
59. Kezic J., Taylor S., Gupta S., Planck S.R., Rosenzweig H.L., Rosenbaum J.T. Endotoxin-induced uveitis is primarily dependent on radiation-resistant cells and on MyD88 but not TRIF. J. Leukoc. Biol. 2011, 90:305-311.
60. Khan A.I., Heit B., Andonegui G., Colarusso P., Kubes P. Lipopolysaccharide: a p38 MAPK-dependent disrupter of neutrophil chemotaxis. Microcirculation 2005, 12:421-432.
61. Koizumi K., Poulaki V., Doehmen S., Welsandt G., Radetzky S., Lappas A., Kociok N., Kirchhof B., Joussen A.M. Contribution of TNF-alpha to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo. Invest. Ophthalmol. Vis. Sci. 2003, 44:2184-2191.
62. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 2008, 8:279-289.
63. Kozhich A.T., Chan C.C., Gery I., Whitcup S.M. Recurrent intraocular inflammation in endotoxin-induced uveitis. Invest. Ophthalmol. Vis. Sci. 2000, 41:1823-1826.
64. Krausgruber T., Blazek K., Smallie T., Alzabin S., Lockstone H., Sahgal N., Hussell T., Feldmann M., Udalova I.A. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 2011, 12:231-238.
65. Kumar M.V., Nagineni C.N., Chin M.S., Hooks J.J., Detrick B. Innate immunity in the retina: toll-like receptor (TLR) signaling in human retinal pigment epithelial cells. J. Neuroimmunol. 2004, 153:7-15.
66. Kurokawa T., Kikuchi T., Ohta K., Imai H., Yoshimura N. Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology 2003, 110:2040-2044.
67. Lambe T., Leung J.C., Ferry H., Bouriez-Jones T., Makinen K., Crockford T.L., Jiang H.R., Nickerson J.M., Peltonen L., Forrester J.V., Cornall R.J. Limited peripheral T cell anergy predisposes to retinal autoimmunity. J. Immunol. 2007, 178:4276-4283.
68. Latkany P.A., Jabs D.A., Smith J.R., Rosenbaum J.T., Tessler H., Schwab I.R., Walton R.C., Thorne J.E., Maguire A.M. Multifocal choroiditis in patients with familial juvenile systemic granulomatosis. Am. J. Ophthalmol. 2002, 134:897-904.
69. Lee R.W., Dick A.D. Treat early and embrace the evidence in favour of anti-TNF-alpha therapy for Behçet's uveitis. Br. J. Ophthalmol. 2010, 94:269-270.
70. Lee Y.K., Mazmanian S.K. Has the microbiota played a critical role in the evolution of the adaptive immune system?. Science 2010, 330:1768-1773.
71. Liberek A., Korzon M., Bernatowska E., Kurenko-Deptuch M., Rytlewska M. Vaccination-related Mycobacterium bovis BCG infection. Emerg. Infect. Dis. 2006, 12:860-862.
72. Liversidge J., Dick A., Gordon S. Nitric oxide mediates apoptosis through formation of peroxynitrite and Fas/Fas-ligand interactions in experimental autoimmune uveitis. Am. J. Pathol. 2002, 160:905-916.
73. Maartens G., Wilkinson R.J. Tuberculosis. Lancet 2007, 370:2030-2043.
74. Market E., Papavasilliou N. VDJ recombination and the evolution of the adaptive immune system. PLoS Biol. 2003, 24-26.
75. Martin T.M., Kurz D.E., Rosenbaum J.T. Genetics of uveitis. Ophthalmol. Clin. North. Am. 2003, 16:555-565.
76. Masters S.L., Simon A., Aksentijevich I., Kastner D.L. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu. Rev. Immunol. 2009, 27:621-668.
77. Mattapallil M.J., Silver P.B., Mattapallil J.J., Horai R., Karabekian Z., McDowell J.H., Chan C.C., James E.A., Kwok W.W., Sen H.N., Nussenblatt R.B., David C.S., Caspi R.R. Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cells. J. Immunol. 2011, 187:1977-1985.
78. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 1994, 12:991-1045.
79. Matzinger P., Kamala T. Tissue-based class control: the other side of tolerance. Nat. Rev. Immunol. 2011, 11:221-230.
80. McMenamin P.G., Crewe J., Morrison S., Holt P.G. Immunomorphologic studies of macrophages and MHC class II-positive dendritic cells in the iris and ciliary body of the rat, mouse, and human eye. Invest. Ophthalmol. Vis. Sci. 1994, 35:3234-3250.
81. Medzhitov R., Janeway C.A. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997, 91:295-298.
82. Miceli-Richard C., Lesage S., Rybojad M., Prieur A.M., Manouvrier-Hanu S., Häfner R., Chamaillard M., Zouali H., Thomas G., Hugot J.P. CARD15 mutations in Blau syndrome. Nat. Genet. 2001, 29:19-20.
83. Mizuki N., Meguro A., Ota M., Ohno S., Shiota T., Kawagoe T., Ito N., Kera J., Okada E., Yatsu K., Song Y.W., Lee E.B., Kitaichi N., Namba K., Horie Y., Takeno M., Sugita S., Mochizuki M., Bahram S., Ishigatsubo Y., Inoko H. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat. Genet. 2010, 42:703-706.
84. Neven B., Marvillet I., Terrada C., Ferster A., Boddaert N., Couloignier V., Pinto G., Pagnier A., Bodemer C., Bodaghi B., Tardieu M., Prieur A.M., Quartier P. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum. 2010, 62:258-267.
85. Noah P.W. The role of microorganisms in psoriasis. Semin. Dermatol. 1990, 9:269-276.
86. Nussenblatt R.B., Gery I., Ballintine E.J., Wacker W.B. Cellular immune responsiveness of uveitis patients to retinal S-antigen. Am. J. Ophthalmol. 1980, 89:173-179.
87. O'Neill L.A. Primer: toll-like receptor signaling pathways - what do rheumatologists need to know?. Nat. Clin. Pract. Rheumatol. 2008, 4:319-327.
88. Opremcak E.M., Cowans A.B., Orosz C.G., Adams P.W., Whisler R.L. Enumeration of autoreactive helper T lymphocytes in uveitis. Invest. Ophthalmol. Vis. Sci. 1991, 32:2561-2567.
89. Palm N.W., Medzitov R. Pattern recognition receptors and control of adaptive immunity. Immunol. Rev. 2009, 227:221-233.
90. Petty R.E., Johnston W., McCormick A.Q., Hunt D.W.C., Rootman J., Rollins D.F. Uveitis and arthritis induced by adjuvant: clinical, immunologic and histologic characteristics. J. Rheumatol. 1989, 16:499-505.
91. Pointon J.J., Harvey D., Karaderi T., Appleton L.H., Farrar C., Stone M.A., Sturrock R.D., Brown M.A., Wordsworth B.P. Elucidating the chromosome 9 association with AS; CARD9 is a candidate gene. Genes Immun. 2011, 12:319-320.
92. Raveney B.J., Copland D.A., Dick A.D., Nicholson L.B. TNFR1-dependent regulation of myeloid cell function in experimental autoimmune uveoretinitis. J. Immunol. 2009, 183:2321-2329.
93. Raveney B.J., Copland D.A., Calder C.J., Dick A.D., Nicholson L.B. TNFR1 signalling is a critical checkpoint for developing macrophages that control of T-cell proliferation. Immunology 2010, 131:340-349.
94. Relvas L.J., Bouffioux C., Marcet B., Communi D., Makhoul M., Horckmans M., Blero D., Bruyns C., Caspers L., Boeynaems J.M., Willermain F. Extracellular nucleotides and interleukin-8 production by ARPE cells: potential role of danger signals in blood-retinal barrier activation. Invest. Ophthalmol. Vis. Sci. 2009, 50:1241-1246.
95. Remmers E.F., Cosan F., Kirino Y., Ombrello M.J., Abaci N., Satorius C., Le J.M., Yang B., Korman B.D., Cakiris A., Aglar O., Emrence Z., Azakli H., Ustek D., Tugal-Tutkun I., Akman-Demir G., Chen W., Amos C.I., Dizon M.B., Kose A.A., Azizlerli G., Erer B., Brand O.J., Kaklamani V.G., Kaklamanis P., Ben-Chetrit E., Stanford M., Fortune F., Ghabra M., Ollier W.E., Cho Y.H., Bang D., O'Shea J., Wallace G.R., Gadina M., Kastner D.L., Gül A. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat. Genet. 2010, 42:698-702.
96. Robertson M.J., Erwig L.P., Liversidge J., Forrester J.V., Rees A.J., Dick A.D. Retinal microenvironment controls resident and infiltrating macrophage function during uveoretinitis. Invest. Ophthalmol. Vis. Sci. 2002, 43:2250-2257.
97. Rodrigues L.C., Diwan V.K., Wheeler J.G. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int. J. Epidemiol. 1993, 22:1154-1158.
98. Ronald P.C., Beutler B. Plant and animal sensors of conserved microbial signatures. Science 2010, 330:1061-1064.
99. Rosenbaum J.T., McDevitt H.O., Guss R.B., Egbert P.R. Endotoxin-induced uveitis in rats as a model for human disease. Nature 1980, 286:611-613.
100. Rosenbaum J.T., Woods A., Kezic J., Planck S.R., Rosenzweig H.L. Contrasting ocular effects of local versus systemic endotoxin. Invest. Ophthalmol. Vis. Sci. 2011, 2011-epub.
101. Rosenzweig H.L., Martin T.M., Planck S.R., Galster K., Jann M.M., Davey M.P., Kobayashi K., Flavell R.A., Rosenbaum J.T. Activation of NOD2 in vivo induces IL-1 beta production in the eye via caspase-1 but results in ocular inflammation independently of IL-1 signaling. J. Leukoc. Biol. 2008, 84:529-536.
102. Rosenzweig H.L., Galster K., Planck S., Rosenbaum J.T. NOD1 expression in the eye and functional contribution to IL-1{beta} dependent ocular inflammation in mice. Invest. Ophthalmol. Vis. Sci. 2009, 50:1746-1753.
103. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-831.
104. Shakeel A., Gouws P. Muckle-Wells syndrome: another cause of acute anterior uveitis. Eye 2007, 21:849-850.
105. Silva L.C., Ortigosa L.C., Benard G. Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. Immunotherapy 2010, 2:817-833.
106. Song Z., Marzilli L., Greenlee B.M., Chen E.S., Silver R.F., Askin F.B., Teirstein A.S., Zhang Y., Cotter R.J., Moller D.R. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J. Exp. Med. 2005, 201:755-767.
107. Strober W. Inside the microbial and immune labyrinth: gut microbes: friends or fiends?. Nat. Med. 2010, 16:1195-1197.
108. Su S.B., Silver P.B., Grajewski R.S., Agarwal R.K., Tang J., Chan C.C., Caspi R.R. Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. J. Immunol. 2005, 175:6303-6310.
109. Takeuchi M., Usui Y., Okunuki Y., Zhang L., Ma J., Yamakawa N., Hattori T., Kezuka T., Sakai J., Goto H. Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis. Invest. Ophthalmol. Vis. Sci. 2010, 51:3067-3075.
110. Tamissia N., LeMoigne V., Calzetti F., Donini M., Gasperini S., Ear T., Cloutier A., Martinez F.O., Fabbri M., Locati M., Mantovani A., McDonald P.P., Cassatella M.A. The MyD88-independent pathway is not mobilized in human neutrophils stimulated via TLR4. J. Immunol. 2007, 178:7344-7356.
111. Taurog J.D., Richardson J.A., Croft J.T., Simmons W.A., Zhou M., Fernández-Sueiro J.L., Balish E., Hammer R.E. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 1994, 180:2359-2364.
112. Teoh S.C., Sharma S., Hogan A., Lee R., Ramanan A.V., Dick A.D. Tailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndrome. Br. J. Ophthalmol. 2007, 91:263-264.
113. Terrada C., Neven B., Boddaert N., Souied E.H., Prieur A.M., Quartier P., Lehoang P., Bodaghi B. Ocular modifications in a young girl with cryopyrin-associated periodic syndromes responding to interleukin-1 receptor antagonist anakinra. J. Ophthalmic Inflamm. Infect. 2011, Apr 9. Epub ahead of print.
114. Uppal G.S., Shah A.N., Tossounis C.M., Tappin M.J. Bilateral panuveitis following intravesical BCG immunotherapy for bladder carcinoma. Ocul. Immunol. Inflamm. 2010, 18:292-296.
115. Wacker W.B. Proctor lecture. Experimental allergic uveitis. Investigations of retinal autoimmunity and the immunopathologic responses evoked. Invest. Ophthalmol. Vis. Sci. 1991, 32:3119-3128.
116. Wacker W.B., Lipton M.M. Experimental allergic uveitis: homologous retina as uveitogenic antigen. Nature 1965, 206:253-254.
117. Wallace G.R., Niemczyk E. Genetics in ocular inflammation - basic principles. Ocul. Immunol. Inflamm. 2011, 19:10-18.
118. Weaver C.T., Hatton R.D. Interplay between the Th17 and T reg cell lineages: a co-evolutionary perspective. Nat. Rev. Immunol. 2009, 9:883-889.
119. Wildner G., Diedrichs-Möehring M. Autoimmune uveitis and antigenic mimicry of environmental antigens. Autoimmun. Rev. 2004, 3:383-387.
120. Wildner G., Diedrichs-Moehring M. Multiple autoantigen mimotopes of infectious agents induce autoimmune arthritis and uveitis in lewis rats. Clin. Diagn. Lab. Immunol. 2005, 12:677-679.
121. Wildner G., Diedrichs-Mohring M. Autoimmune uveitis induced by molecular mimicry of peptides from rotavirus, bovine casein and retinal S-antigen. Eur. J. Immunol. 2003, 33:2577-2587.
122. Wilson M.E., Fineberg H.V., Colditz G.A. Geographic latitude and the efficacy of bacillus Calmette-Guerin vaccine. Clin. Infect. Dis. 1995, 20:982-991.
123. Woods A.C. Studies on the actions of toxins and protein degeneration products on the eye. Arch. Ophthalmol. 1916, 45:451-464.
124. Xu H., Chen M., Mayer E.J., Forrester J.V., Dick A.D. Turnover of resident retinal microglia in the normal adult mouse. Glia 2007, 55:1189-1198.
125. Yamamoto J.H., Minami M., Inaba G., Masuda K., Mochizuki M. Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease. Br. J. Ophthalmol. 1993, 77:584-589.
126. Yanagihori H., Oyama N., Nakamura K., Mizuki N., Oguma K., Kaneko F. Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility: an involvement of Th1 immunoreactivity against Streptococcus Sanguinis antigen. J. Invest. Dermatol. 2006, 126:1534-1540.
127. Yu J.R., Leslie K.S. Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response. Curr. Allergy Asthma Rep. 2011, 11:12-20.
128. Zhernakova A., Festen E.M., Franke L., Trynka G., van Diemen C.C., Monsuur A.J., Bevova M., Nijmeijer R.M., van 't Slot R., Heijmans R., Boezen H.M., van Heel D.A., van Bodegraven A.A., Stokkers P.C., Wijmenga C., Crusius J.B., Weersma R.K. Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am. J. Hum. Genet. 2008, 82:1202-1210.